Ironwood Pharmaceuticals
IRWD
#7047
Rank
S$0.89 B
Marketcap
S$5.45
Share price
3.62%
Change (1 day)
234.68%
Change (1 year)

Earnings for Ironwood Pharmaceuticals (IRWD)

Earnings in 2026 (TTM): S$0.22 Billion

According to Ironwood Pharmaceuticals 's latest financial reports the company's current earnings are S$0.36 Billion. In 2025 the company made an earning of S$88.88 Million, an increase over its 2024 earnings that were of S$82.75 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ironwood Pharmaceuticals from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$0.22 B147.64%
2025 S$88.88 M7.4%
2024 S$82.75 M-106.88%
2023 -S$1.21 Billion-475.59%
2022 S$0.32 B25.8%
2021 S$0.25 B84.32%
2020 S$0.13 B84.69%
2019 S$74.81 M-125.13%
2018 -S$0.3 Billion100.62%
2017 -S$0.15 Billion43.12%
2016 -S$0.11 Billion-42.73%
2015 -S$0.19 Billion-24.76%
2014 -S$0.25 Billion-30.49%
2013 -S$0.35 Billion275.65%
2012 -S$92.19 Million11.56%
2011 -S$82.63 Million9.38%
2010 -S$75.55 Million-15.21%
2009 -S$89.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AstraZeneca
AZN
S$18.61 B 8,451.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Nektar Therapeutics
NKTR
-S$0.2 Billion-188.77%๐Ÿ‡บ๐Ÿ‡ธ USA